![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 1, 353-361, April 2003
Institute of Environmental Health Sciences, Wayne State University,
Detroit, Michigan
Diabetes is a major cause of morbidity and mortality, and complications
resulting from diabetes have been attributed in part to increased
oxidative stress. Glutathione S-transferases (GSTs) constitute a major protective mechanism against oxidative stress. Studies of the expression and activity of GSTs during diabetes are
inconclusive, with both increased and decreased GST expression being
reported in vivo. Insulin and glucagon effects on GST expression and
the signaling pathway involved in the glucagon regulation of GST
expression were examined in primary cultured rat hepatocytes. The
addition of insulin resulted in the elevation of alpha-class GST
protein levels, whereas alpha- and pi-class GST protein levels were
markedly decreased in hepatocytes cultured with glucagon. In contrast,
mu-class GST protein expression was unaffected by insulin or glucagon
treatment. Insulin concentrations
1 nM resulted in increased GST
activities and alpha-class GST protein levels, whereas glucagon
concentrations
20 nM decreased alpha- and pi-class protein levels and
activity. Treatment of cells with 8-bromo-cAMP or dibutyryl-cAMP also
resulted in decreased alpha- and pi-class GST protein levels.
Pretreatment with
N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide (H89), a selective inhibitor of protein kinase A, before
glucagon addition markedly attenuated the glucagon effect. This study
demonstrates that insulin and glucagon regulate, in an opposing manner,
the expression of alpha-class GSTs and that glucagon completely
inhibits pi-class GST expression in vitro, suggesting that hepatic GST
expression may be decreased during diabetes. Furthermore, the present
study implicates cAMP and protein kinase A in mediating the inhibitory
effect of glucagon on GST expression.
This article has been cited by other articles:
![]() |
S. K. Kim, M. A. Abdelmegeed, and R. F. Novak THE MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK) INHIBITOR PD98059 ELEVATES PRIMARY CULTURED RAT HEPATOCYTE GLUTATHIONE LEVELS INDEPENDENT OF INHIBITING MEK Drug Metab. Dispos., April 1, 2006; 34(4): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kim, M. A. Abdelmegeed, and R. F. Novak Identification of the Insulin Signaling Cascade in the Regulation of Alpha-Class Glutathione S-Transferase Expression in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1255 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kim, K. J. Woodcroft, S. S. Khodadadeh, and R. F. Novak Insulin Signaling Regulates {gamma}-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 99 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Abdelmegeed, S. K. Kim, K. J. Woodcroft, and R. F. Novak Acetoacetate Activation of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in Primary Cultured Rat Hepatocytes: Role of Oxidative Stress J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 728 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kim, K. J. Woodcroft, S. G. Kim, and R. F. Novak INSULIN AND GLUCAGON SIGNALING IN REGULATION OF MICROSOMAL EPOXIDE HYDROLASE EXPRESSION IN PRIMARY CULTURED RAT HEPATOCYTES Drug Metab. Dispos., October 1, 2003; 31(10): 1260 - 1268. [Abstract] [Full Text] [PDF] |
||||